Literature DB >> 17220183

Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model.

Kenji Tsujimae1, Shingo Suzuki, Shingo Murakami, Yoshihisa Kurachi.   

Abstract

Rapidly activating K(+) current (I(Kr)) blockers prolong action potential (AP) duration (APD) in a reverse-frequency-dependent manner and may induce arrhythmias, including torsade de pointes in the ventricle. The I(Kr) blocker dofetilide has been approved for treatment of atrial arrhythmias, including fibrillation. There are, however, a limited number of studies on the action of I(Kr) blockers on atrial AP. When we tested a mathematical model of the human atrial AP (M Courtemanche, RJ Ramirez, S Nattel. Am J Physiol Heart Circ Physiol 275: H301-H321, 1998) to examine the effects of dofetilide-type I(Kr) blockade, this model could not reproduce the reverse-frequency-dependent nature of I(Kr) blockade on atrial APD. We modified the model by introducing a slowly activating K(+) current activation parameter. As the slow time constant was increased, dofetilide-type blockade induced more prominent reverse-frequency-dependent APD prolongation. Using the modified model, we also examined the effects of two more types of I(Kr) blockade similar to those of quinidine and vesnarinone. Voltage- and time-dependent block of I(Kr) through the onset of inhibition by quinidine is much faster than by vesnarinone. When we incorporated the kinetics of the effects of these drugs on I(Kr) into the model, we found that quinidine-type blockade caused a reverse-frequency-dependent prolongation of APD that was similar to the effect of dofetilide-type blockade, whereas vesnarinone-type blockade did not. This finding coincides with experimental observations. The lack of the reverse frequency dependence in vesnarinone-type blockade was accounted for by the slow development of I(Kr) blockade at depolarized potentials. These results suggest that the voltage- and time-dependent nature of I(Kr) blockade by drugs may be critical for the phenotype of the drug effect on atrial AP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220183     DOI: 10.1152/ajpheart.01083.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  14 in total

Review 1.  Human atrial fibrillation: insights from computational electrophysiological models.

Authors:  Donald M Bers; Eleonora Grandi
Journal:  Trends Cardiovasc Med       Date:  2011-07       Impact factor: 6.677

2.  Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.

Authors:  Lin Wu; Jihua Ma; Hong Li; Chao Wang; Eleonora Grandi; Peihua Zhang; Antao Luo; Donald M Bers; John C Shryock; Luiz Belardinelli
Journal:  Circulation       Date:  2011-04-11       Impact factor: 29.690

3.  Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation.

Authors:  Eleonora Grandi; Sandeep V Pandit; Niels Voigt; Antony J Workman; Dobromir Dobrev; José Jalife; Donald M Bers
Journal:  Circ Res       Date:  2011-09-15       Impact factor: 17.367

4.  Rate-Dependent Role of IKur in Human Atrial Repolarization and Atrial Fibrillation Maintenance.

Authors:  Martin Aguilar; Jianlin Feng; Edward Vigmond; Philippe Comtois; Stanley Nattel
Journal:  Biophys J       Date:  2017-05-09       Impact factor: 4.033

5.  Models of HERG gating.

Authors:  Glenna C L Bett; Qinlian Zhou; Randall L Rasmusson
Journal:  Biophys J       Date:  2011-08-03       Impact factor: 4.033

6.  Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.

Authors:  Daniel Scherer; Katharina von Löwenstern; Edgar Zitron; Eberhard P Scholz; Ramona Bloehs; Sven Kathöfer; Dierk Thomas; Alexander Bauer; Hugo A Katus; Christoph A Karle; Claudia Kiesecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

7.  Verapamil reduces incidence of reentry during ventricular fibrillation in pigs.

Authors:  Qi Jin; Derek J Dosdall; Li Li; Jack M Rogers; Raymond E Ideker; Jian Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-29       Impact factor: 4.733

Review 8.  Anti-arrhythmic strategies for atrial fibrillation: The role of computational modeling in discovery, development, and optimization.

Authors:  Eleonora Grandi; Mary M Maleckar
Journal:  Pharmacol Ther       Date:  2016-09-06       Impact factor: 12.310

9.  Impact of sarcoplasmic reticulum calcium release on calcium dynamics and action potential morphology in human atrial myocytes: a computational study.

Authors:  Jussi T Koivumäki; Topi Korhonen; Pasi Tavi
Journal:  PLoS Comput Biol       Date:  2011-01-27       Impact factor: 4.475

Review 10.  Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing.

Authors:  Gary R Mirams; Mark R Davies; Yi Cui; Peter Kohl; Denis Noble
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.